SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech binary events
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (123)10/7/2003 5:46:53 PM
From: Icebrg  Read Replies (1) of 295
 
>>NPSP, March(?) '04>>

I don't think that will be very binary. We already more or less know from the PATH study that the stuff works. The current studies will just define how well it does. Forteo, which is a very similar drug, has already been approved etc.

The only binary thing around here, that I am aware of is the preclinical study of certain cancer "risks". Forteo had some rats with cancer, if Preos does better it would truly be binary. If not, I don't think it will matter much as Forteo also had those problems.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News